Clinical Trial Update: Post-marketing Study Assessing the Long-Term Safety of Abatacept

View source ↗

Summary

A completed post-marketing study evaluating the long-term safety of abatacept for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED